Thursday, September 5, 2019

Polypill holds promise for tackling cardiovascular disease

Heart attacks and strokes are collectively the leading cause of death in most low- and middle-income countries (LMICs) worldwide. Treatment with four drugs—aspirin, a statin, an angiotensin converting-enzyme (ACE)-inhibitor, and a beta blocker—improves survival and quality of life among patients who have had a heart attack or stroke in the past; however, fewer than a quarter of eligible patients in LMICs receive these medications due to concerns about pill burden and cost.